U.S. Stem Cell, Inc. Annual Return On Assets in % from 2012 to 2022

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
U.S. Stem Cell, Inc. quarterly/annual Return On Assets history and growth rate from 2012 to 2022.
  • U.S. Stem Cell, Inc. Return On Assets for the quarter ending December 31, 2022 was -2.52K %, a 86.4% decline year-over-year.
  • U.S. Stem Cell, Inc. annual Return On Assets for 2022 was -2.52K %, a 86.4% decline from 2021.
  • U.S. Stem Cell, Inc. annual Return On Assets for 2021 was -1.35K %, a 41% increase from 2020.
  • U.S. Stem Cell, Inc. annual Return On Assets for 2020 was -2.29K %, a 330% decline from 2019.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 -2.52K -1.17K -86.4% Jan 1, 2022 Dec 31, 2022
2021 -1.35K +939 +41% Jan 1, 2021 Dec 31, 2021
2020 -2.29K -1.76K -330% Jan 1, 2020 Dec 31, 2020
2019 -533 -431 -423% Jan 1, 2019 Dec 31, 2019
2018 -102 +119 +53.8% Jan 1, 2018 Dec 31, 2018
2017 -220 +311 +58.5% Jan 1, 2017 Dec 31, 2017
2016 -532 +131 +19.7% Jan 1, 2016 Dec 31, 2016
2015 -662 +272 +29.1% Jan 1, 2015 Dec 31, 2015
2014 -934 +712 +43.2% Jan 1, 2014 Dec 31, 2014
2013 -1.65K +116 +6.61% Jan 1, 2013 Dec 31, 2013
2012 -1.76K Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.